Fecal transplant with chemotherapy for triple negative breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether giving a fecal transplant (a procedure that puts healthy bacteria from a donor's stool into your gut) along with chemotherapy can help treat triple negative breast cancer. It aims to see if this approach improves the effectiveness of the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with triple negative breast cancer and are about to start chemotherapy (before surgery).
- You are willing to provide stool and blood samples.
- You are able to swallow capsules.
- You have not had treatment with anti-PD-1 drugs before (for phase 2).
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control during the trial and for 120 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
This study tests whether giving patients healthy donor stool bacteria (fecal microbiota transplantation) can reduce or prevent nausea, diarrhea, and other stomach or bowel problems caused by cancer treatment. It is for people with extrapulmonary neuroendocrine tumors who have had gastrointestinal side effects during their first three treatment cycles.
This trial tests whether a treatment that targets your gut bacteria (microbiome) can help fight triple-negative breast cancer before surgery. It is for people with newly diagnosed, untreated triple-negative breast cancer that has not spread far.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This trial studies whether giving a fecal microbiota transplant (a stool-based sample from a carefully screened donor) alongside immune checkpoint inhibitors can improve outcomes in people with lung cancer. It aims to change the gut bacteria to help the immune system work better against the cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.